2022 Q3 Form 10-Q Financial Statement

#000149315222022064 Filed on August 11, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $5.063M $3.015M $1.744M
YoY Change 36.6% -33.14% -26.29%
Cost Of Revenue $4.466M $2.709M $1.654M
YoY Change 50.91% -16.07% -18.2%
Gross Profit $597.2K $306.2K $90.51K
YoY Change -20.07% -76.12% -73.74%
Gross Profit Margin 11.8% 10.16% 5.19%
Selling, General & Admin $1.293M $1.080M $1.563M
YoY Change 18.48% 21.8% 70.31%
% of Gross Profit 216.47% 352.7% 1726.65%
Research & Development $58.98K $56.58K $138.9K
YoY Change -40.2% -49.28% 23.33%
% of Gross Profit 9.88% 18.47% 153.49%
Depreciation & Amortization $8.030K $8.140K $8.560K
YoY Change -54.86% -56.7% -53.43%
% of Gross Profit 1.34% 2.66% 9.46%
Operating Expenses $1.656M $2.077M $1.702M
YoY Change 39.22% 78.11% 65.17%
Operating Profit -$1.059M -$1.771M -$1.611M
YoY Change 139.33% -1627.17% 134.99%
Interest Expense $10.73K $10.60K $3.260K
YoY Change -925.38% -948.0% -552.78%
% of Operating Profit
Other Income/Expense, Net $17.08K $10.60K $185.0K
YoY Change -52.45% -92.9%
Pretax Income -$1.042M -$1.761M -$1.423M
YoY Change 155.46% -763.77% 79.35%
Income Tax
% Of Pretax Income
Net Earnings -$1.042M -$1.761M -$1.423M
YoY Change 155.46% -763.77% 79.35%
Net Earnings / Revenue -20.58% -58.4% -81.57%
Basic Earnings Per Share -$0.13 -$0.23 -$0.41
Diluted Earnings Per Share -$131.0K -$0.23 -$307.8K
COMMON SHARES
Basic Shares Outstanding 7.954M shares 7.801M shares 4.622M shares
Diluted Shares Outstanding 7.954M shares 7.801M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $21.08M $20.61M $22.03M
YoY Change 823.15% 1154.15% 573.58%
Cash & Equivalents $21.08M $20.61M $22.03M
Short-Term Investments
Other Short-Term Assets $1.102M $2.888M $1.774M
YoY Change -4.75% 45.33% -14.06%
Inventory $614.6K $401.8K $1.006M
Prepaid Expenses
Receivables $77.14K $140.5K $191.0K
Other Receivables $0.00 $78.94K $50.76K
Total Short-Term Assets $22.88M $24.12M $25.06M
YoY Change 478.65% 459.73% 326.0%
LONG-TERM ASSETS
Property, Plant & Equipment $76.22K $84.69K $617.7K
YoY Change -74.01% -76.58% 41.43%
Goodwill
YoY Change
Intangibles $1.830K $1.830K
YoY Change
Long-Term Investments
YoY Change
Other Assets $14.75K $14.75K $14.75K
YoY Change -39.0% -8.5% 83.0%
Total Long-Term Assets $581.8K $616.1K $1.265M
YoY Change -39.11% -39.35% 16.84%
TOTAL ASSETS
Total Short-Term Assets $22.88M $24.12M $25.06M
Total Long-Term Assets $581.8K $616.1K $1.265M
Total Assets $23.46M $24.74M $26.32M
YoY Change 377.89% 364.53% 277.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.360M $207.6K $729.0K
YoY Change 57.35% -80.96% -15.24%
Accrued Expenses $1.081M $997.3K $855.7K
YoY Change -6.52% -16.12% -31.36%
Deferred Revenue $4.435M $5.935M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.914M $7.177M $7.107M
YoY Change 35.1% 12.63% -13.65%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Other Long-Term Liabilities $405.3K $432.5K $459.5K
YoY Change 992.96% 434.21% 219.15%
Total Long-Term Liabilities $405.3K $432.5K $459.5K
YoY Change -26.92% -27.57% -30.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.914M $7.177M $7.107M
Total Long-Term Liabilities $405.3K $432.5K $459.5K
Total Liabilities $7.319M $7.610M $7.567M
YoY Change 29.04% 9.18% -14.88%
SHAREHOLDERS EQUITY
Retained Earnings -$33.01M -$31.97M
YoY Change
Common Stock $80.00 $80.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $16.14M $17.13M $18.75M
YoY Change
Total Liabilities & Shareholders Equity $23.46M $24.74M $26.32M
YoY Change 377.89% 364.53% 277.93%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$1.042M -$1.761M -$1.423M
YoY Change 155.46% -763.77% 79.35%
Depreciation, Depletion And Amortization $8.030K $8.140K $8.560K
YoY Change -54.86% -56.7% -53.43%
Cash From Operating Activities $488.6K -$1.425M $192.9K
YoY Change -178.87% -12.4% -60.18%
INVESTING ACTIVITIES
Capital Expenditures -$16.40K $0.00 -$13.95K
YoY Change -100.0% 13.14%
Acquisitions
YoY Change
Other Investing Activities $0.00 $2.250K
YoY Change 50.0%
Cash From Investing Activities -$16.40K $2.250K -$13.95K
YoY Change -251.01% 13.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $22.00M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 19.70M
YoY Change -100.0% 3730.25%
NET CHANGE
Cash From Operating Activities 488.6K -1.425M 192.9K
Cash From Investing Activities -16.40K 2.250K -13.95K
Cash From Financing Activities 0.000 0.000 19.70M
Net Change In Cash 472.2K -1.422M 19.87M
YoY Change -26.27% -12.62% 1915.13%
FREE CASH FLOW
Cash From Operating Activities $488.6K -$1.425M $192.9K
Capital Expenditures -$16.40K $0.00 -$13.95K
Free Cash Flow $505.0K -$1.425M $206.8K
YoY Change -181.52% -12.24% -58.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001482541
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q2 us-gaap Goodwill
Goodwill
usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2022Q2 CEAD Convertible Preferred Stock Converted To Securities
ConvertiblePreferredStockConvertedToSecurities
usd
CY2021Q2 CEAD Convertible Preferred Stock Converted To Securities
ConvertiblePreferredStockConvertedToSecurities
usd
CEAD Convertible Preferred Stock Converted To Securities
ConvertiblePreferredStockConvertedToSecurities
usd
CY2022Q2 CEAD Deemed Dividend Preferred Stock On Down Round
DeemedDividendPreferredStockOnDownRound
usd
CY2021Q2 CEAD Deemed Dividend Preferred Stock On Down Round
DeemedDividendPreferredStockOnDownRound
usd
CEAD Deemed Dividend Preferred Stock On Down Round
DeemedDividendPreferredStockOnDownRound
usd
CY2022Q2 CEAD Stock Issued During Period Value Cashless Exercise Of Prepaid Warrants
StockIssuedDuringPeriodValueCashlessExerciseOfPrepaidWarrants
usd
CEAD Stock Issued During Period Value Cashless Exercise Of Prepaid Warrants
StockIssuedDuringPeriodValueCashlessExerciseOfPrepaidWarrants
usd
CY2021Q2 CEAD Common Shares Issued In Settlement Of Legal Dispute
CommonSharesIssuedInSettlementOfLegalDispute
usd
CEAD Common Stock Issued For Other Expense
CommonStockIssuedForOtherExpense
usd
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
usd
CEAD Increase Decrease In Operating Deposit
IncreaseDecreaseInOperatingDeposit
usd
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
usd
CEAD Payments For Redemption Of Preferred Stock
PaymentsForRedemptionOfPreferredStock
usd
CEAD Cash Proceeds From Sale Of Preferred Stock And Warrants Net Of Issuance Costs
CashProceedsFromSaleOfPreferredStockAndWarrantsNetOfIssuanceCosts
usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
CEAD Unpaid Purchases Of Equipment And Other Assets
UnpaidPurchasesOfEquipmentAndOtherAssets
usd
CEAD Noncash Investing And Financing Activities Conversion Of Series B Preferred Stock
NoncashInvestingAndFinancingActivitiesConversionOfSeriesBPreferredStock
usd
CEAD Noncash Investing And Financing Activities Deemed Dividend Preferred Stock Arising On Down Round
NoncashInvestingAndFinancingActivitiesDeemedDividendPreferredStockArisingOnDownRound
usd
CEAD Cashless Exercise Or Prepaid Warrants
CashlessExerciseOrPrepaidWarrants
usd
CY2022Q2 CEAD Remaining Performance Obligations Related To Engineering Only Paid Contracts
RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts
usd
CEAD Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Exercised Weighted Average Remaining Contractual Terms
SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms
CEAD Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
shares
CEAD Class Of Warrant Or Right Weighted Average Exercise Price Expired
ClassOfWarrantOrRightWeightedAverageExercisePriceExpired
CEAD Class Of Warrant Or Right Expired Aggregate Intrinsic Value
ClassOfWarrantOrRightExpiredAggregateIntrinsicValue
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54286
dei Entity Registrant Name
EntityRegistrantName
CEA INDUSTRIES INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-3911608
dei Entity Address Address Line1
EntityAddressAddressLine1
385 South Pierce Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite C
dei Entity Address City Or Town
EntityAddressCityOrTown
Louisville
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80027
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80027
dei City Area Code
CityAreaCode
(303)
dei Local Phone Number
LocalPhoneNumber
993-5271
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7953974 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20611388 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2159608 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
172760 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
181942 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
140473 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
179444 usd
CY2022Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
78943 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
401757 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
378326 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2887593 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1273720 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
24120154 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
3991098 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
84687 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
77346 usd
CY2021Q4 us-gaap Goodwill
Goodwill
631064 usd
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1830 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1830 usd
CY2022Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
14747 usd
CY2021Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
14747 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
514816 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
565877 usd
CY2022Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
616080 usd
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1290864 usd
CY2022Q2 us-gaap Assets
Assets
24736234 usd
CY2021Q4 us-gaap Assets
Assets
5281962 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1044536 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1345589 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5935270 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2839838 usd
CY2022Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
46373 usd
CY2021Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
83625 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
37078 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
37078 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
113999 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
100139 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
7177256 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4406269 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
432496 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
486226 usd
CY2022Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
432496 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
486226 usd
CY2022Q2 us-gaap Liabilities
Liabilities
7609752 usd
CY2021Q4 us-gaap Liabilities
Liabilities
4892495 usd
CY2022Q2 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.00001
CY2022Q2 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0 shares
CY2022Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2021Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
3300 shares
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
3300 shares
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Preferred Carrying Amount
RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
3960000 usd
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
3960000 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7953974 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7953974 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1600835 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1600835 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
80 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
16 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
49091496 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
25211017 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31965094 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-28781566 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
17126482 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-3570533 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24736234 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5281962 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3014885 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4509505 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4759312 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6876034 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
2708646 usd
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
3227181 usd
us-gaap Cost Of Revenue
CostOfRevenue
4362565 usd
us-gaap Cost Of Revenue
CostOfRevenue
5249104 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
306239 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
1282324 usd
us-gaap Gross Profit
GrossProfit
396747 usd
us-gaap Gross Profit
GrossProfit
1626930 usd
CY2022Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
309690 usd
CY2021Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
168042 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
560705 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
345187 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
56577 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
111546 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
195495 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
224184 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1080094 usd
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
886758 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2391871 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1627231 usd
CY2022Q2 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
631064 usd
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
631064 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
2077425 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
1166346 usd
us-gaap Operating Expenses
OperatingExpenses
3779135 usd
us-gaap Operating Expenses
OperatingExpenses
2196602 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1771186 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
115978 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3382388 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-569672 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
150518 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
185000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
43518 usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
10600 usd
CY2021Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1254 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
13860 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1972 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10600 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
149264 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
198860 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
41546 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1760586 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
265242 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3183528 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-528126 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1760586 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
265242 usd
us-gaap Net Income Loss
NetIncomeLoss
-3183528 usd
us-gaap Net Income Loss
NetIncomeLoss
-528126 usd
CEAD Convertible Preferred Stock Converted To Securities
ConvertiblePreferredStockConvertedToSecurities
35984 usd
CEAD Deemed Dividend Preferred Stock On Down Round
DeemedDividendPreferredStockOnDownRound
439999 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1760586 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
265242 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3659511 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-528126 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7801211 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1582998 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6220600 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1579938 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7801211 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1605526 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6220600 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1579938 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
18754188 usd
CY2022Q2 CEAD Adjustments To Additional Paid In Capital Fair Value Of Vested Stock Options Granted To Employees
AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToEmployees
126635 usd
CY2022Q2 CEAD Adjustments To Additional Paid In Capital Fair Value Of Vested Stock Options Granted To Directors
AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToDirectors
6245 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1760586 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
17126482 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-3570533 usd
CEAD Adjustments To Additional Paid In Capital Fair Value Of Vested Stock Options Granted To Employees
AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToEmployees
159573 usd
CEAD Adjustments To Additional Paid In Capital Fair Value Of Vested Stock Options Granted To Directors
AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToDirectors
29656 usd
CEAD Stock Issued During Period Value Common Shares Issued In Settlement Of Restricted Stock Units Issued To Directors
StockIssuedDuringPeriodValueCommonSharesIssuedInSettlementOfRestrictedStockUnitsIssuedToDirectors
24994 usd
CEAD Adjustments To Additional Paid In Capital Fair Value Of Restricted Stock Units Issued To Directors
AdjustmentsToAdditionalPaidInCapitalFairValueOfRestrictedStockUnitsIssuedToDirectors
11173 usd
CEAD Stock Issued During Period Value Reverse Stock Splits
StockIssuedDuringPeriodValueReverseStockSplits
0 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
21711131 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1980000 usd
CEAD Adjustments To Additional Paid In Capital Dividends On Preferred Stock
AdjustmentsToAdditionalPaidInCapitalDividendsOnPreferredStock
-35984 usd
us-gaap Net Income Loss
NetIncomeLoss
-3183528 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
17126482 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-1925290 usd
CY2021Q2 CEAD Adjustments To Additional Paid In Capital Fair Value Of Vested Stock Options Granted To Employees
AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToEmployees
15336 usd
CY2021Q2 CEAD Adjustments To Additional Paid In Capital Fair Value Of Vested Stock Options Granted To Directors
AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToDirectors
70 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
265242 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-1644642 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1333698 usd
CEAD Stock Issued During Period Value Common Shares To Be Issued In Settlement Of Legal Dispute
StockIssuedDuringPeriodValueCommonSharesToBeIssuedInSettlementOfLegalDispute
67000 usd
CEAD Adjustments To Additional Paid In Capital Fair Value Of Vested Stock Options Granted To Employees
AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToEmployees
143770 usd
CEAD Adjustments To Additional Paid In Capital Fair Value Of Vested Stock Options Granted To Directors
AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToDirectors
6412 usd
us-gaap Net Income Loss
NetIncomeLoss
-528126 usd
us-gaap Net Income Loss
NetIncomeLoss
-528126 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-1644642 usd
us-gaap Net Income Loss
NetIncomeLoss
-3183528 usd
us-gaap Net Income Loss
NetIncomeLoss
-528126 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16697 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
37180 usd
us-gaap Share Based Compensation
ShareBasedCompensation
225396 usd
us-gaap Share Based Compensation
ShareBasedCompensation
21748 usd
CEAD Common Stock Issued For Other Expense
CommonStockIssuedForOtherExpense
67000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-9182 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
23213 usd
us-gaap Inventory Write Down
InventoryWriteDown
-34417 usd
us-gaap Inventory Write Down
InventoryWriteDown
-10945 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-4060 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-8042 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
51061 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
98913 usd
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
631064 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-48153 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
224183 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-10986 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
106299 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
1692816 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
949152 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-317453 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
124583 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
3095431 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
331585 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1972 usd
CEAD Increase Decrease In Operating Deposit
IncreaseDecreaseInOperatingDeposit
-16122 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-39870 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-130156 usd
CEAD Increase Decrease In Deferred Compensation Accrued Equity Compensation
IncreaseDecreaseInDeferredCompensationAccruedEquityCompensation
-37251 usd
CEAD Increase Decrease In Deferred Compensation Accrued Equity Compensation
IncreaseDecreaseInDeferredCompensationAccruedEquityCompensation
108945 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1231669 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1141802 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13948 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15316 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2250 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1500 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11698 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13816 usd
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
35984 usd
CEAD Payments For Redemption Of Preferred Stock
PaymentsForRedemptionOfPreferredStock
1980000 usd
CEAD Cash Proceeds From Sale Of Preferred Stock And Warrants Net Of Issuance Costs
CashProceedsFromSaleOfPreferredStockAndWarrantsNetOfIssuanceCosts
21711131 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
514200 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19695147 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
514200 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
18451780 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-641418 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2159608 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2284881 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
20611388 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1643463 usd
CEAD Unpaid Purchases Of Equipment And Other Assets
UnpaidPurchasesOfEquipmentAndOtherAssets
16400 usd
CEAD Noncash Investing And Financing Activities Conversion Of Series B Preferred Stock
NoncashInvestingAndFinancingActivitiesConversionOfSeriesBPreferredStock
1980000 usd
CEAD Noncash Investing And Financing Activities Deemed Dividend Preferred Stock Arising On Down Round
NoncashInvestingAndFinancingActivitiesDeemedDividendPreferredStockArisingOnDownRound
439999 usd
CEAD Cashless Exercise Or Prepaid Warrants
CashlessExerciseOrPrepaidWarrants
2 usd
CY2022Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
228378 usd
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
272199 usd
CY2022Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
195 usd
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1050 usd
CY2022Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
230145 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
22000000 usd
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On January 17, 2022, the Company’s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty. Such reverse stock split was implemented effective January 27, 2022
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
240125224 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1600835 shares
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84E_eus-gaap--UseOfEstimates_zsna6ZRlZN5e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_z1FJCmUcRbZd">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets and goodwill, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
196456 usd
CY2022Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
56961 usd
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
91379 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
401757 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
378326 usd
CY2022Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2022Q2 us-gaap Cash
Cash
20611000 usd
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
20361000 usd
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
22528 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
7882061 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
164579 shares
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
631064 usd
us-gaap Cost Of Goods And Services Sold Overhead
CostOfGoodsAndServicesSoldOverhead
14997 usd
CY2021 us-gaap Cost Of Goods And Services Sold Overhead
CostOfGoodsAndServicesSoldOverhead
13589 usd
CY2022Q2 us-gaap Other Inventory In Transit
OtherInventoryInTransit
47735 usd
CY2022Q2 CEAD Prepaid Inventory Expenses
PrepaidInventoryExpenses
2720000 usd
CY2021Q4 CEAD Prepaid Inventory Expenses
PrepaidInventoryExpenses
1069000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3014885 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4509505 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4759312 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6876034 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5935270 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2839838 usd
CY2022Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1030830 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2193204 usd
CY2021Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1193251 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3073616 usd
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
9698000 usd
CY2022Q2 CEAD Remaining Performance Obligations Related To Partial Equipment Paid Contracts
RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts
9698000 usd
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
9698000 usd
CY2022Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
7623772 shares
CY2022Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
5.14
CY2022Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
183979 usd
CY2021Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
186605 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
95627 usd
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
71557 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
188144 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
130693 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zHyRBSxJI1n2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_ztESRW8g2fSe">Concentrations</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Two customers accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z0X9znMsLQy9" title="Concentration risk percentage">53</span>% and <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zjyvuwGI5o8">12</span>% of the Company’s revenue for the three months ended June 30, 2022 and one customer accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zyymO20X4H8e" title="Concentration risk percentage">47</span>% of the Company’s revenue for the six months ended June 30, 2022. Three customers accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210401__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zYzYYQOS6eLb">28</span>%, <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210401__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zPeabknhHrUc">27</span>%, and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210401__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zJ4lvKFmpxm3">11</span>% of the Company’s revenue for the three months ended June 30, 2021 and three customers accounted for <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zCI3HdThpgU9">18</span>%, <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zxDPbCHX6xC8">18</span>% and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zHmuN2hNKUNh">13</span>% of the Company’s revenue for the six months ended June 30, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three customers accounted for <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zgHb4nl5b2od">60</span>%, <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_ztTh5HI7UX4k">25</span>% and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zLgRGvuBfbW8">10</span>% of the Company’s accounts receivable as of June 30, 2022. Two customers accounted for <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zlCXmpK7lt">68</span>%, and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zpQwkk5cm6qe">23</span>% of the Company’s accounts receivable as of December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CEAD Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm
P55M
CY2022Q2 CEAD Class Of Warrant Or Right Outstanding Aggregate Intrinsic Value
ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue
0 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
514816 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
113999 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
432496 usd
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y7M6D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0363 pure
us-gaap Operating Lease Payments
OperatingLeasePayments
50273 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
60931 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
124897 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
128643 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
132503 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
136473 usd
CY2022Q2 CEAD Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
11654 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
595101 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
48606 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
546495 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
192463 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1044536 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1345589 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
297748 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
289472 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
213061 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
212126 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
84687 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
77346 usd
us-gaap Depreciation
Depreciation
16697 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
207640 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
616056 usd
CY2022Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
21613 usd
CY2021Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
27592 usd
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
325372 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
322873 usd
CY2022Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
183979 usd
CY2021Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
186605 usd
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
305932 usd
CY2021Q3 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
1260000 usd
CY2021Q4 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
1365000 usd
CEAD Deemed Dividend Preferred Stock On Down Round
DeemedDividendPreferredStockOnDownRound
439999 usd
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7953974 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7953974 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
240125244 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
240125244 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1600835 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1600835 shares
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
22000000 usd
CY2022Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
169530 shares
CY2022Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
170382 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
227719 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
9.59
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P33M
CY2021Q4 CEAD Class Of Warrant Or Right Outstanding Aggregate Intrinsic Value
ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue
0 usd
CEAD Class Of Warrant Or Right Granted
ClassOfWarrantOrRightGranted
7566435 shares
CEAD Class Of Warrant Or Right Weighted Average Exercise Price Granted
ClassOfWarrantOrRightWeightedAverageExercisePriceGranted
4.89
CEAD Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Granted Weighted Average Remaining Contractual Terms
SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms
P55M
CEAD Class Of Warrant Or Right Granted Aggregate Intrinsic Value
ClassOfWarrantOrRightGrantedAggregateIntrinsicValue
212978 usd
CEAD Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
-170382 shares
CEAD Class Of Warrant Or Right Weighted Average Exercise Price Exercised
ClassOfWarrantOrRightWeightedAverageExercisePriceExercised
0.01
CEAD Class Of Warrant Or Right Exercised Aggregate Intrinsic Value
ClassOfWarrantOrRightExercisedAggregateIntrinsicValue
212978 usd
CY2022Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
7623772 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P55M
CY2022Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
24275000 usd
CY2022Q2 CEAD Net Operating Loss Carry Forward Expected To Expire Amount
NetOperatingLossCarryForwardExpectedToExpireAmount
11196000 usd
CY2022Q2 CEAD Nols Usage Against Taxable Income Percentage
NolsUsageAgainstTaxableIncomePercentage
0.80 pure
CY2022Q2 CEAD Nols Usage Against Taxable Income Percentage
NolsUsageAgainstTaxableIncomePercentage
0.80 pure
CEAD Nols Carryforwards Term Description
NolsCarryforwardsTermDescription
three-year
CY2021Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
usd

Files In Submission

Name View Source Status
cead-20220630_cal.xml Edgar Link unprocessable
0001493152-22-022064-index-headers.html Edgar Link pending
0001493152-22-022064-index.html Edgar Link pending
0001493152-22-022064.txt Edgar Link pending
0001493152-22-022064-xbrl.zip Edgar Link pending
cead-20220630.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
cead-20220630_def.xml Edgar Link unprocessable
cead-20220630_lab.xml Edgar Link unprocessable
cead-20220630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending